Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
125.08
-0.32 (-0.26%)
Official Closing Price
Updated: 7:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abbott Laboratories
< Previous
1
2
3
4
5
6
7
8
9
...
50
51
Next >
Looking Into Abbott Laboratories's Recent Short Interest
↗
July 18, 2025
Via
Benzinga
Invesco, Vistra, Dell, Coinbase Trend In Midday Trade: S&P 500 Hits Record High
↗
July 18, 2025
Via
Stocktwits
Topics
Stocks
These S&P500 stocks have an unusual volume in today's session
↗
July 18, 2025
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.
Via
Chartmill
Top S&P500 movers in Friday's session
↗
July 18, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top S&P500 gainers and losers in today's session.
Via
Chartmill
P/E Ratio Insights for Abbott Laboratories
↗
July 17, 2025
Via
Benzinga
A Preview Of Abbott Laboratories's Earnings
↗
July 16, 2025
Via
Benzinga
Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield
↗
July 18, 2025
Abbott Laboratories' dividend is safe, the pipeline is strong, and the outlook for growth is positive, making the July price dip a buying opportunity.
Via
MarketBeat
These Analysts Revise Their Forecasts On Abbott Following Q2 Results
↗
July 18, 2025
Via
Benzinga
Microsoft To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday
↗
July 18, 2025
Via
Benzinga
ABT Q1 Deep Dive: Growth in Devices, Product Pipeline, and Tariff Mitigation Shape Outlook
July 18, 2025
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of...
Via
StockStory
Topics
Economy
World Trade
Abbott Reports 12% Growth in Device Sales
↗
July 17, 2025
Via
The Motley Fool
Top S&P500 movers in Thursday's session
↗
July 17, 2025
Curious about the top performers within the S&P500 index one hour before the close of the markets on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive...
Via
Chartmill
Why Abbott Laboratories (ABT) Shares Are Plunging Today
July 17, 2025
Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.1% in the afternoon session after the company reported second-quarter earnings that beat analyst expectations but...
Via
StockStory
Unusual volume S&P500 stocks in Thursday's session
↗
July 17, 2025
Let's have a look at the S&P500 stocks with an unusual volume in today's session.
Via
Chartmill
Nasdaq 100 Sets New Records, Small Caps Outperform: What's Moving Markets Thursday?
↗
July 17, 2025
U.S. equities climbed on Thursday, with the S&P 500 briefly testing a record high 6,300 level at midday in New York, bolstered by strong earnings and upbeat retail sales data that reinforced investor...
Via
Benzinga
Abbott Reports 10.5% EPS Growth for Fiscal Q2
↗
July 17, 2025
Via
The Motley Fool
Topics
Economy
World Trade
Stay informed with the top movers within the S&P500 index on Thursday.
↗
July 17, 2025
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Via
Chartmill
Abbott (ABT) Q2 2025 Earnings Call Transcript
↗
July 17, 2025
Via
The Motley Fool
Topics
Earnings
Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors
↗
July 17, 2025
Abbott posted Q2 revenue of $11.14 billion and EPS of $1.26, raised 2025 earnings guidance, and saw strong growth in diabetes and heart device sales.
Via
Benzinga
Which S&P500 stocks are gapping on Thursday?
↗
July 17, 2025
Thursday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Via
Chartmill
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours
↗
July 17, 2025
Abbott’s sales of continuous glucose monitors were $1.9 billion in the second quarter, marking a growth of 21.4% on a reported basis, the company said.
Via
Stocktwits
Topics
Artificial Intelligence
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss
↗
July 17, 2025
The company issued a light outlook for 2025 organic sales growth despite beating second-quarter forecasts.
Via
Investor's Business Daily
Topics
Government
Stocks
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
July 17, 2025
Via
Benzinga
Wondering what's happening in today's S&P500 pre-market session?
↗
July 17, 2025
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Via
Chartmill
Dow Futures Edge Lower As Trump, Powell Feud Escalates, Earnings Take Centerstage: TSMC, PEP, UAL, GE Among Stocks To Watch
↗
July 17, 2025
While Dow Jones futures were down 0.12% at the time of writing, the S&P 500 futures were up 0.06%.
Via
Stocktwits
Topics
ETFs
Economy
Government
Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates
July 17, 2025
Healthcare product and device company Abbott Laboratories (NYSE:ABT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 7.4% year on year to $11.14 billion. Its non-GAAP profit of...
Via
StockStory
Earnings Scheduled For July 17, 2025
↗
July 17, 2025
Via
Benzinga
Abbott Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
↗
July 16, 2025
Via
Benzinga
Nvidia To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday
↗
July 16, 2025
Via
Benzinga
Abbott Laboratories (ABT) Q2 Earnings: What To Expect
July 15, 2025
Healthcare product and device company Abbott Laboratories (NYSE:ABT) will be announcing earnings results this Thursday morning. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
50
51
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.